Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation

Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation

Abstract Background The aim of this study is to investigate the effect of tumor characteristics and parameters of treatment response in predicting biochemical disease-free survival (BFS) for patients with intermediate or high risk prostate cancer treated by combined definitive external beam radiatio...

Full description

Bibliographic Details
Main Authors: Fady B. Geara, Muhammad Bulbul, Raja B. Khauli, Therese Y. Andraos, Mirna Abboud, Abdelatif Al Mousa, Nasim Sarhan, Ahmed Salem, Hamza Ghatasheh, Anoud Alnsour, Zeina Ayoub, Ibrahim Abu Gheida, Maya Charafeddine, Mohammed Shahait, Ali Shamseddine, Rami Abu Gheida, Jamal Khader
Format: Article
Language:English
Published: BMC 2017-09-01
Series:Radiation Oncology
Subjects:
Prostate cancer
External beam radiation therapy
Androgen deprivation
Nadir PSA
Online Access:http://link.springer.com/article/10.1186/s13014-017-0884-y

Internet

http://link.springer.com/article/10.1186/s13014-017-0884-y

Similar Items